Interleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding

Background Atherosclerosis is an inflammatory process that develops in individuals with known risk factors that include hypertension and hyperlipidaemia, influenced by diet. However, the interplay between diet, inflammatory mechanisms and vascular risk factors requires further research. We hypothesised that interleukin-1 (IL-1) signaling in the vessel wall would raise arterial blood pressure and promote atheroma. Methodology/Principal Findings Apoe−/− and Apoe−/−/IL-1R1−/− mice were fed high fat diets for 8 weeks, and their blood pressure and atherosclerosis development measured. Apoe−/−/IL-R1−/− mice had a reduced blood pressure and significantly less atheroma than Apoe−/− mice. Selective loss of IL-1 signaling in the vessel wall by bone marrow transplantation also reduced plaque burden (p<0.05). This was associated with an IL-1 mediated loss of endothelium-dependent relaxation and an increase in vessel wall Nox 4. Inhibition of IL-1 restored endothelium-dependent vasodilatation and reduced levels of arterial oxidative stress. Conclusions/Significance The IL-1 cytokine system links atherogenic environmental stimuli with arterial inflammation, oxidative stress, increased blood pressure and atherosclerosis. This is the first demonstration that inhibition of a single cytokine can block the rise in blood pressure in response to an environmental stimulus. IL-1 inhibition may have profound beneficial effects on atherogenesis in man.

[1]  R. de Caterina,et al.  The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Kenny,et al.  The role of fish oil in hypertension. , 2007, Connecticut medicine.

[3]  K. Kondo,et al.  Antihypertensive effect and safety of dietary alpha-linolenic acid in subjects with high-normal blood pressure and mild hypertension. , 2007, Journal of oleo science.

[4]  G. Dusting,et al.  The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. , 2005, Cardiovascular research.

[5]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[6]  P. Andrew,et al.  Guanylyl cyclase mediates ANP-induced vasoconstriction of murine splenic vessels. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  G. Biondi-Zoccai,et al.  Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction , 2008, Circulation.

[8]  R. Turner,et al.  Interleukin-1 and Nitric Oxide Increase NADPH Oxidase Activity in Human Coronary Artery Smooth Muscle Cells , 2003, Medical Principles and Practice.

[9]  D. Crossman,et al.  Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[10]  D. Harrison,et al.  Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[11]  Y. Sharabi,et al.  Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. , 2007, Atherosclerosis.

[12]  K. Reue,et al.  Cholesterol and Cholate Components of an Atherogenic Diet Induce Distinct Stages of Hepatic Inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.

[13]  P. Young,et al.  Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[15]  J. Lekakis,et al.  Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis , 2008, Circulation.

[16]  K. Tezuka,et al.  Interleukin-1beta induces tissue- and cell type-specific expression of adhesion molecules in vivo. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[17]  A. Vollmer,et al.  High-fat diet elevates blood pressure and cerebrovascular muscle Ca(2+) current. , 2000, Hypertension.

[18]  R. de Caterina,et al.  The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibition , 2006, Proceedings of the National Academy of Sciences.

[19]  D. Harrison,et al.  Endothelial Regulation of Vasomotion in ApoE-Deficient Mice: Implications for Interactions Between Peroxynitrite and Tetrahydrobiopterin , 2001, Circulation.

[20]  K. Rockett,et al.  Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. , 2003, The Journal of clinical investigation.

[21]  G. Getz,et al.  Diet and Murine Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[22]  A. Vollmer,et al.  High-Fat Diet Elevates Blood Pressure and Cerebrovascular Muscle Ca2+ Current , 2000 .

[23]  N. Camp,et al.  Genetic variation at the interleukin-1 locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromes. , 2002, Clinical science.

[24]  Bryan Williams,et al.  Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials , 2006, Journal of hypertension.

[25]  S. Kaufman,et al.  Myogenic responses and compliance of mesenteric and splenic vasculature in the rat. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  J. Arnal,et al.  Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. , 1998, Circulation.

[27]  B. Rosner,et al.  Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. , 2005, JAMA.

[28]  A. Mantovani,et al.  The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. , 1994, Immunology today.

[29]  R. Cotran,et al.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.

[30]  David Evans,et al.  Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice. , 2006, The American journal of pathology.

[31]  M. Seishima,et al.  Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[32]  C. Devlin,et al.  Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Levine,et al.  Interleukin-1 Receptor Signaling Mediates Atherosclerosis Associated With Bacterial Exposure and/or a High-Fat Diet in a Murine Apolipoprotein E Heterozygote Model: Pharmacotherapeutic Implications , 2004, Circulation.

[34]  S. Malozowski,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[35]  N. Alp,et al.  Increased Endothelial Tetrahydrobiopterin Synthesis by Targeted Transgenic GTP-Cyclohydrolase I Overexpression Reduces Endothelial Dysfunction and Atherosclerosis in ApoE-Knockout Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[36]  F. Ohsuzu,et al.  Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E–Deficient Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[37]  Jiqiu Chen,et al.  Hypertension Does Not Account for the Accelerated Atherosclerosis and Development of Aneurysms in Male Apolipoprotein E/Endothelial Nitric Oxide Synthase Double Knockout Mice , 2001, Circulation.

[38]  C. Holt,et al.  Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease , 1996 .

[39]  J. Gunn,et al.  Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery model. , 2005, Cardiovascular research.

[40]  F. Sacks,et al.  Does Fish Oil Lower Blood Pressure? A Meta‐Analysis of Controlled Trials , 1993, Circulation.

[41]  P. Libby,et al.  Inducible interleukin-1 gene expression in human vascular smooth muscle cells. , 1986, The Journal of clinical investigation.